Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest

Prostate

Volumn 49, Issue 4, 2001, Pages 285-292

  Ikezoe, Takayuki ^a   Chen, Sophie S ^b   Heber, David ^a   Taguchi, Hirokuni ^c   Phillip Koeffler, H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Baicalin; Cell cycle; p27; PARP

Indexed keywords

BAICALIN; LIPOCORTIN 5; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P27;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CLONAL ANERGY; CLONOGENIC ASSAY; DRUG EFFECT; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

ANNEXIN A5; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; FEMALE; FLAVONOIDS; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; MACROPHAGE-1 ANTIGEN; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0035212167     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10024     Document Type: Article

References (35)

1. Cancer patient use of nonproven therapy: 5-year follow-up study
2. Unconventional medicine in the United States: Prevalence, costs, and patterns of use
3. Trends in alternative medicine use in the United States, 1990-1997
4. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer
5. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: A preliminary investigation on human cell lines and patients
6. Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease
7. Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES
8. Induction of apoptosis and down-regulation of bcl-6 in mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES
9. PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo
10. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer
11. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer
12. Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines
13. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF 1 in myeloid leukemia
14. 5, 6-Trans-16-ene-vitamin D3: A new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells
15. CCAAT/enhancer binding protein c is a potential retinoid target gene in acute promyelocytic leukemia treatment
16. Early redistribution of plasma membrane phosphotidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
17. Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium and phospholipid-binding proteins
18. 1 phase
19. Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines
20. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells
21. The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice
22. The herbal medicine shosaiko-to inhibits the growth of malignant melanoma cells by upregulating Fas-mediated apoptosis and arresting cell cycle through downregulation of cyclin dependent kinases
23. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9)
24. Yama/Cpp32b, a mammalian homologue of CED-3, is a CrmA inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase
25. Role of poly (ADP-ribose) polymerase (PARP) cleavage in apoptosi
26. Cdk inhibitors in development of cancer
27. p21 is a universal inhibitor of cyclin kinases
28. The p21 cdk-interacting protein cip1 is a potential inhibitor of G1 cyclindependent kinase
29. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
30. p27, a novel inhibitor of G1 cyclin cdk protein kinase activity, is related to p21
31. Clinical relevance of expression the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer
32. p27 expression correlates with prognosis in patients with hypopharyngeal cancer
33. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer
34. 19-Nor vitamin-D analogs: A new class of potent inhibitors of proliferation and inducer of differentiation of human myeloid leukemia cell lines
35. WAF1, potent mediator of p53 tumor suppression